SPRINT peripheral nerve stimulation for chronic posterior sacroiliac joint (PSIJC) low back pain
Official title: Peripheral Nerve Stimulation With the SPRINT® System in Chronic Posterior Sacroiliac Joint Complex Pain
Run by Medical University of South Carolina · NCT07166952 · Data updated 2026-11-12
This study will try a temporary SPRINT peripheral nerve stimulator to see if it reduces chronic PSIJC-related lower back pain in adults who have already tried physical therapy and medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 2 sites (Charleston, South Carolina and 1 other locations) |
| Status | Recruiting |
| Started | October 26, 2025 |
| Main results expected | October 26, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | November 14, 2025 |
| Trial ID | NCT07166952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (over 18) with chronic PSIJC-related low back pain who are severely debilitated (ODI >40%), have tried at least three months of conservative care, and are scheduled for a commercial SPRINT procedure authorized by their insurer.
✕Probably not a fit
Patients with acute SIJ trauma, active spinal neoplasm or inflammation, recent SIJ steroid injection (within 1 month) or sacral lateral branch RFA (within 6 months), pregnancy, or other contraindications to neuromodulation are unlikely to be appropriate or to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults with chronic posterior sacroiliac joint complex (PSIJC) pain who remain debilitated despite at least three months of conservative treatment. Participants scheduled for a commercial SPRINT PNS case will receive a minimally invasive percutaneous lead placed under the skin to electrically stimulate sacral lateral branch nerves. Outcomes will track pain, disability (Oswestry Disability Index >40% at baseline), and safety over follow-up to determine whether temporary SPRINT PNS provides sustained symptom relief. Enrollment excludes recent SIJ injections or recent radiofrequency ablation, active spinal neoplasm, recent spinal surgery, pregnancy, or other contraindications to neuromodulation.
Why it matters
Potential benefit: If successful, the SPRINT PNS approach could reduce pain and disability from PSIJC and offer a less invasive option that may decrease reliance on injections or more invasive procedures.
How similar studies have gone: Prior studies of permanent neurostimulation have shown reduced pain and disability, and early reports of temporary SPRINT PNS suggest durable relief for some patients, though large randomized data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sacroiliac pain as diagnosed above * Subject greater than 18 years old * Subject is severely debilitated by SIJ pain, with initial ODI score \> 40% * Subject received conservative treatment for at least three months including physiotherapy and pain medication * Subject is able to understand and consent to the study and device management and participating in follow-up surveys * Subject is scheduled for a commercial SPRINT case that has been authorized through their healthcare insurance Exclusion Criteria: * Pregnancy * Subject is under the age of 18 years * Acute traumatic injury of the sacral iliac joint * Active inflammation or neoplastic infiltration of the SIJ * Neoplastic diseases of the spine * Spinal surgery within the last three months * Sacroiliac joint steroid injection within the past 1 month or sacral lateral branch radiofrequency ablation within the past 6 months * Contraindication for Neuromodulation Device (severe psychiatric disease, severe coagulation disorder, acute infection, active autoimmune disease with immunosuppression)
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Ameet Nagpal — Medical University of South Carolina
- Study coordinator: Lisa Research Assistant/Coordinator
- Email: mockl@musc.edu
- Phone: 8438762211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medical Massage Therapy for Subacute Lower Back Pain in Active-Duty Service Members
This study tests whether adding medical massage therapy to standard care can shorten duty-restriction periods and reduce pain for active-duty service members with subacute lower back pain.
-
Lower back pain: stem cell and exosome infusion vs placebo
This study tests whether an umbilical cord blood–derived stem cell and exosome infusion can help adults with chronic degenerative lower back pain compared with placebo.
-
Dynamic sitting with prototype office chairs for lower back pain
This study will test whether using two types of dynamic office chairs instead of a static chair can prevent or reduce lower back pain in office workers who tend to develop pain.
-
Intrathecal CNTX-3001 for intractable chronic low back pain
This trial will test CNTX-3001, a non-opioid medicine given into the spinal fluid, to see if it is safe and helps adults with long-standing, treatment-resistant moderate to severe low back pain.
-
Three dry needling approaches for chronic low back pain
This study will see if three types of dry needling—dry needling alone, dry needling with high-rate PENS, and dry needling with low-rate PENS—reduce pain and improve quality of life for adults with chronic low back pain.
-
Robotic EMMA versus therapist-delivered lower back massage
This test compares a robotic device called EMMA to a certified massage therapist for adults with lower back pain to see if patient experience differs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.